John Wiley & Sons B Net Assets
John Wiley & Sons B net assets. Based on the latest financial reports, John Wiley & Sons B (WLYB) has net assets worth $848.24 Million USD as of April 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.59 Billion) and total liabilities ($1.74 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore WLYB shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $848.24 Million |
| % of Total Assets | 32.73% |
| Annual Growth Rate | 5.77% |
| 5-Year Change | -25.74% |
| 10-Year Change | -15.44% |
| Growth Volatility | 16.67 |
Net Assets of John Wiley & Sons B (1986–2026)
Net assets of John Wiley & Sons B from 1986 to 2026. This chart illustrates how John Wiley & Sons B's net assets have evolved over time, based on quarterly financial data. See WLYB equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for John Wiley & Sons B (1986–2026)
The table below shows the annual net assets of John Wiley & Sons B from 1986 to 2026. For live market cap and overall valuation, see market value of John Wiley & Sons B.
| Year | Net Assets | Change |
|---|---|---|
| 2026-04-30 | $848.24 Million | +12.77% |
| 2025-04-30 | $752.21 Million | +1.69% |
| 2024-04-30 | $739.72 Million | -29.22% |
| 2023-04-30 | $1.05 Billion | -8.51% |
| 2022-04-30 | $1.14 Billion | +4.67% |
| 2021-04-30 | $1.09 Billion | +16.89% |
| 2020-04-30 | $933.62 Million | -20.97% |
| 2019-04-30 | $1.18 Billion | -0.77% |
| 2018-04-30 | $1.19 Billion | +18.68% |
| 2017-04-30 | $1.00 Billion | -3.28% |
| 2016-04-30 | $1.04 Billion | -1.70% |
| 2015-04-30 | $1.06 Billion | -10.76% |
| 2014-04-30 | $1.18 Billion | +19.62% |
| 2013-04-30 | $988.36 Million | -2.87% |
| 2012-04-30 | $1.02 Billion | +4.06% |
| 2011-04-30 | $977.89 Million | +35.36% |
| 2010-04-30 | $722.44 Million | +40.68% |
| 2009-04-30 | $513.52 Million | -25.48% |
| 2008-04-30 | $689.12 Million | +30.14% |
| 2007-04-30 | $529.51 Million | +31.77% |
| 2006-04-30 | $401.84 Million | +1.33% |
| 2005-04-30 | $396.57 Million | -4.45% |
| 2004-04-30 | $415.06 Million | +20.66% |
| 2003-04-30 | $344.00 Million | +24.35% |
| 2002-04-30 | $276.65 Million | +25.74% |
| 2001-04-30 | $220.02 Million | +27.37% |
| 2000-04-30 | $172.74 Million | +6.50% |
| 1999-04-30 | $162.20 Million | +0.87% |
| 1998-04-30 | $160.80 Million | +24.65% |
| 1997-04-30 | $129.00 Million | +9.32% |
| 1996-04-30 | $118.00 Million | +19.43% |
| 1995-04-30 | $98.80 Million | +20.05% |
| 1994-04-30 | $82.30 Million | +15.43% |
| 1993-04-30 | $71.30 Million | +2.44% |
| 1992-04-30 | $69.60 Million | -26.66% |
| 1991-04-30 | $94.90 Million | +1.39% |
| 1990-04-30 | $93.60 Million | -1.27% |
| 1989-04-30 | $94.80 Million | -0.32% |
| 1988-04-30 | $95.10 Million | +3.03% |
| 1987-04-30 | $92.30 Million | +2.56% |
| 1986-04-30 | $90.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to John Wiley & Sons B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2529.6% over the analyzed period, indicating profitable operations and earnings retention.
John Wiley & Sons B Net Assets Breakdown (April 2026)
John Wiley & Sons B net assets breakdown by equity component as of April 2026.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.74 Billion | 204.91% |
| Common Stock | $83.18 Million | 9.81% |
| Other Comprehensive Income | $-442.22 Million | -52.13% |
| Total Equity | $848.24 Million | 100.00% |
John Wiley & Sons B Competitors by Market Cap
The table below lists competitors of John Wiley & Sons B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arko Corp
NASDAQ:ARKO
|
$445.38 Million |
|
Phat Dat Real Estate Development Corp
VN:PDR
|
$445.45 Million |
|
Zhejiang Sunrise Garment Group Co Ltd
SHG:605138
|
$445.51 Million |
|
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
|
$445.55 Million |
|
Reunert
JSE:RLO
|
$444.93 Million |
|
Shanxi Antai Group Co Ltd
SHG:600408
|
$444.93 Million |
|
Gotland Rederi AB Series A
ST:GOTL-A
|
$444.52 Million |
|
Anji Foodstuff Co Ltd
SHG:603696
|
$444.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in John Wiley & Sons B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 752,206,000 to 848,242,000, a change of 96,036,000 (12.8%).
- Net income of 221,617,000 contributed positively to equity growth.
- Dividend payments of 74,358,000 reduced retained earnings.
- Share repurchases of 100,082,000 reduced equity.
- Other comprehensive income increased equity by 36,702,000.
- Other factors increased equity by 12,157,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $221.62 Million | +26.13% |
| Dividends Paid | $74.36 Million | -8.77% |
| Share Repurchases | $100.08 Million | -11.8% |
| Other Comprehensive Income | $36.70 Million | +4.33% |
| Other Changes | $12.16 Million | +1.43% |
| Total Change | $- | 12.77% |
Book Value vs Market Value Analysis
This analysis compares John Wiley & Sons B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.19x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 35.76x to 3.19x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-04-30 | $1.42 | $50.82 | x |
| 1987-04-30 | $1.48 | $50.82 | x |
| 1988-04-30 | $1.42 | $50.82 | x |
| 1989-04-30 | $1.39 | $50.82 | x |
| 1990-04-30 | $1.39 | $50.82 | x |
| 1991-04-30 | $1.62 | $50.82 | x |
| 1992-04-30 | $1.12 | $50.82 | x |
| 1993-04-30 | $1.20 | $50.82 | x |
| 1994-04-30 | $1.29 | $50.82 | x |
| 1995-04-30 | $1.51 | $50.82 | x |
| 1996-04-30 | $1.82 | $50.82 | x |
| 1997-04-30 | $1.97 | $50.82 | x |
| 1998-04-30 | $2.42 | $50.82 | x |
| 1999-04-30 | $2.45 | $50.82 | x |
| 2000-04-30 | $2.67 | $50.82 | x |
| 2001-04-30 | $3.47 | $50.82 | x |
| 2002-04-30 | $4.39 | $50.82 | x |
| 2003-04-30 | $5.44 | $50.82 | x |
| 2004-04-30 | $6.56 | $50.82 | x |
| 2005-04-30 | $6.39 | $50.82 | x |
| 2006-04-30 | $6.72 | $50.82 | x |
| 2007-04-30 | $9.08 | $50.82 | x |
| 2008-04-30 | $11.62 | $50.82 | x |
| 2009-04-30 | $8.61 | $50.82 | x |
| 2010-04-30 | $12.11 | $50.82 | x |
| 2011-04-30 | $15.94 | $50.82 | x |
| 2012-04-30 | $16.61 | $50.82 | x |
| 2013-04-30 | $16.41 | $50.82 | x |
| 2014-04-30 | $19.87 | $50.82 | x |
| 2015-04-30 | $17.70 | $50.82 | x |
| 2016-04-30 | $17.66 | $50.82 | x |
| 2017-04-30 | $17.24 | $50.82 | x |
| 2018-04-30 | $20.57 | $50.82 | x |
| 2019-04-30 | $20.42 | $50.82 | x |
| 2020-04-30 | $16.61 | $50.82 | x |
| 2021-04-30 | $19.33 | $50.82 | x |
| 2022-04-30 | $20.18 | $50.82 | x |
| 2023-04-30 | $18.54 | $50.82 | x |
| 2024-04-30 | $13.46 | $50.82 | x |
| 2025-04-30 | $13.72 | $50.82 | x |
| 2026-04-30 | $15.93 | $50.82 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently John Wiley & Sons B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.13%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.22%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 3.06x
- Recent ROE (26.13%) is above the historical average (14.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | 8.44% | 3.56% | 1.13x | 2.11x | $-1.40 Million |
| 1987 | 5.42% | 2.19% | 1.17x | 2.12x | $-4.23 Million |
| 1988 | 4.94% | 1.96% | 1.15x | 2.19x | $-4.81 Million |
| 1989 | 4.32% | 1.58% | 1.36x | 2.01x | $-5.38 Million |
| 1990 | 2.88% | 0.96% | 1.13x | 2.66x | $-6.66 Million |
| 1991 | 4.32% | 1.73% | 0.94x | 2.65x | $-5.39 Million |
| 1992 | 4.45% | 1.25% | 1.16x | 3.07x | $-3.86 Million |
| 1993 | 10.80% | 2.82% | 1.24x | 3.09x | $570.00K |
| 1994 | 14.70% | 4.11% | 1.21x | 2.96x | $3.87 Million |
| 1995 | 18.52% | 5.53% | 1.34x | 2.51x | $8.42 Million |
| 1996 | 20.93% | 6.81% | 1.27x | 2.41x | $12.90 Million |
| 1997 | 15.74% | 4.70% | 0.94x | 3.55x | $7.40 Million |
| 1998 | 22.76% | 7.84% | 0.92x | 3.15x | $20.52 Million |
| 1999 | 24.48% | 7.81% | 0.96x | 3.26x | $23.48 Million |
| 2000 | 30.33% | 8.81% | 1.04x | 3.30x | $35.11 Million |
| 2001 | 26.78% | 9.60% | 1.04x | 2.67x | $36.92 Million |
| 2002 | 20.72% | 7.80% | 0.82x | 3.24x | $29.65 Million |
| 2003 | 25.37% | 10.22% | 0.89x | 2.78x | $52.87 Million |
| 2004 | 21.40% | 9.63% | 0.91x | 2.44x | $47.33 Million |
| 2005 | 21.14% | 8.61% | 0.94x | 2.60x | $44.18 Million |
| 2006 | 27.46% | 10.57% | 1.02x | 2.55x | $70.14 Million |
| 2007 | 18.81% | 8.07% | 0.49x | 4.78x | $46.67 Million |
| 2008 | 21.41% | 8.81% | 0.65x | 3.76x | $78.62 Million |
| 2009 | 24.98% | 7.96% | 0.72x | 4.33x | $76.91 Million |
| 2010 | 19.87% | 8.45% | 0.73x | 3.21x | $71.30 Million |
| 2011 | 17.58% | 9.86% | 0.72x | 2.49x | $74.10 Million |
| 2012 | 20.91% | 11.93% | 0.70x | 2.49x | $110.99 Million |
| 2013 | 14.59% | 8.19% | 0.63x | 2.84x | $45.39 Million |
| 2014 | 13.58% | 9.04% | 0.58x | 2.60x | $42.29 Million |
| 2015 | 16.76% | 9.71% | 0.61x | 2.85x | $71.36 Million |
| 2016 | 14.06% | 8.44% | 0.59x | 2.82x | $42.07 Million |
| 2017 | 11.33% | 6.61% | 0.66x | 2.60x | $13.33 Million |
| 2018 | 16.14% | 10.70% | 0.63x | 2.38x | $73.13 Million |
| 2019 | 14.24% | 9.35% | 0.61x | 2.49x | $50.13 Million |
| 2020 | -7.96% | -4.06% | 0.58x | 3.39x | $-167.65 Million |
| 2021 | 13.59% | 7.64% | 0.56x | 3.16x | $39.13 Million |
| 2022 | 12.98% | 7.12% | 0.62x | 2.94x | $34.08 Million |
| 2023 | 1.65% | 0.85% | 0.65x | 2.97x | $-87.27 Million |
| 2024 | -27.08% | -10.70% | 0.69x | 3.68x | $-274.29 Million |
| 2025 | 11.19% | 5.02% | 0.62x | 3.58x | $8.94 Million |
| 2026 | 26.13% | 13.22% | 0.65x | 3.06x | $136.79 Million |
Industry Comparison
This section compares John Wiley & Sons B's net assets metrics with peer companies in the Publishing industry.
Industry Context
- Industry: Publishing
- Average net assets among peers: $452,627,927
- Average return on equity (ROE) among peers: 6.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| John Wiley & Sons B (WLYB) | $848.24 Million | 8.44% | 2.06x | $445.15 Million |
| Dallasnews Corp (DALN) | $70.59 Million | -7.70% | 1.02x | $78.24 Million |
| Educational Development Corporation (EDUC) | $5.30 Million | 22.64% | 0.83x | $7.59 Million |
| Gannett Co Inc (GCI) | $295.37 Million | -26.41% | 7.10x | $298.63 Million |
| Lee Enterprises Incorporated (LEE) | $319.40 Million | 20.10% | 1.04x | $146.50 Million |
| New York Times Company (NYT) | $1.48 Billion | 20.40% | 1.56x | $10.45 Billion |
| Scholastic Corporation (SCHL) | $288.60 Million | 11.05% | 1.33x | $867.31 Million |
| TNL Mediagene Ordinary Shares (TNMG) | $-24.14 Million | 0.00% | 0.00x | $1.56 Million |
| John Wiley & Sons (WLY) | $1.18 Billion | 13.58% | 1.60x | $2.12 Billion |
About John Wiley & Sons B
John Wiley & Sons, Inc., a publisher, provides authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning in the United States, the United Kingdom, Germany, and internationally. It operates through Research and Learning segment. The company's Research segment provides scientific, technical, medical, and scholarly journals, as well as rela… Read more